How do we ensure that not only the rich benefit from cell and gene therapy? Rob Collison of Cambridge Consultants says: It’s about more than cutting costs ...

The current state of in vitro diagnostics is no longer fit for purpose. Inadequate procedures mean that critical insights are often missed, while expenditure statistics on both sides of the Atlantic reveal lagging levels of investment ...

新しいプラットフォームの一環として、ケンブリッジコンサルタンツは、「現在の考え方にとらわれない未来を信じる」という大胆なビジョンステートメントとともに、新しいカンパニーロゴとビジュアルアイデンティティを市場投入しました。新たなブランドは、提供する革新的なサービスを反映し、テクノロジーを活用して「望む未来を手に入れる」という、Capgemini Groupの幅広いミッション、すなわち、インクルーシブで持続可能な未来に沿うようにデザインされています。

Greater process control, lower setup costs and simple equipment programming make it easier than ever for manufacturers to build their automation in-house rather than hire a machine builder ...

A holistic approach is essential to making sure that the security of machines involved in a large-scale autonomous project can be trusted ...

By Lai Chiu Tang’s top six insights into successful medical device design. Designing a medical device is a challenging creative task. Not only must it be safe, reliable, easy to use and have market appeal, the device must be accepted into people’s lives and lifestyles ...

Tough challenges await both the big industry players and the new wave of start=ups with ambitions in warehouse automation ...

While full AI consciousness might be some ways off, there are some exciting developments. The need to train machines more quickly, efficiently, and less expensively is a pressing imperative ...

Cambridge Consultants part of Capgemini, today announced its collaboration with MedTech Innovator Asia Pacific, the world’s leading non-profit accelerator of medical devices ...

With the integration of frog and Cambridge Consultants, Capgemini Invent now comprises a global team of 10,000 strategists, data scientists, product and experience designers, brand experts and technologists ...